As of 2026-03-23, the EV/EBITDA ratio of Tandem Diabetes Care Inc (TNDM) is -31.76. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. TNDM's latest enterprise value is 1,920.25 mil USD. TNDM's TTM EBITDA according to its financial statements is -60.46 mil USD. Dividing these 2 quantities gives us the above TNDM EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.7x - 14.3x | 11.3x |
| Forward P/E multiples | 14.0x - 17.0x | 14.2x |
| Fair Price | (15.63) - (15.92) | (14.56) |
| Upside | -163.0% - -164.1% | -158.7% |
| Date | EV/EBITDA |
| 2026-03-20 | -31.76 |
| 2026-03-19 | -31.55 |
| 2026-03-18 | -30.67 |
| 2026-03-17 | -30.73 |
| 2026-03-16 | -28.47 |
| 2026-03-13 | -28.11 |
| 2026-03-12 | -27.30 |
| 2026-03-11 | -28.76 |
| 2026-03-10 | -28.44 |
| 2026-03-09 | -27.31 |
| 2026-03-06 | -27.60 |
| 2026-03-05 | -29.29 |
| 2026-03-04 | -30.17 |
| 2026-03-03 | -30.54 |
| 2026-03-02 | -32.23 |
| 2026-02-27 | -32.31 |
| 2026-02-26 | -32.86 |
| 2026-02-25 | -33.11 |
| 2026-02-24 | -34.11 |
| 2026-02-23 | -35.65 |
| 2026-02-20 | -31.48 |
| 2026-02-19 | -24.64 |
| 2026-02-18 | -25.12 |
| 2026-02-17 | -25.00 |
| 2026-02-13 | -25.13 |
| 2026-02-12 | -24.83 |
| 2026-02-11 | -25.93 |
| 2026-02-10 | -25.80 |
| 2026-02-09 | -25.06 |
| 2026-02-06 | -25.38 |
| 2026-02-05 | -25.12 |
| 2026-02-04 | -25.17 |
| 2026-02-03 | -25.68 |
| 2026-02-02 | -26.42 |
| 2026-01-30 | -26.19 |
| 2026-01-29 | -26.04 |
| 2026-01-28 | -25.31 |
| 2026-01-27 | -26.48 |
| 2026-01-26 | -26.54 |
| 2026-01-23 | -26.20 |
| 2026-01-22 | -26.98 |
| 2026-01-21 | -27.15 |
| 2026-01-20 | -26.87 |
| 2026-01-16 | -26.50 |
| 2026-01-15 | -27.52 |
| 2026-01-14 | -27.30 |
| 2026-01-13 | -27.33 |
| 2026-01-12 | -27.84 |
| 2026-01-09 | -28.24 |
| 2026-01-08 | -29.14 |